IRIS Accounts Production v25.1.4.42 Other Company accounts True false Pounds 1.1.24 31.12.24 31.12.24 FY FRS 102 Independent examiner Small companies regime for accounts Full Charities SORP true true true true true false true true false true false true 0 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh016766182023-12-31016766182024-12-31016766182024-01-012024-12-31016766182022-12-31016766182023-01-012023-12-31016766182023-12-3101676618ns0:CharitableCompanyLimitedByGuarantee2024-01-012024-12-3101676618ns15:PoundSterling2024-01-012024-12-3101676618ns11:FRS1022024-01-012024-12-3101676618ns11:IndependentExaminationCharity2024-01-012024-12-3101676618ns11:SmallCompaniesRegimeForAccounts2024-01-012024-12-3101676618ns11:FullAccounts2024-01-012024-12-3101676618ns11:CharitiesSORP2024-01-012024-12-3101676618ns16:EnglandWales2024-01-012024-12-3101676618ns11:RegisteredOffice2024-01-012024-12-3101676618ns0:Trustee32024-01-012024-12-3101676618ns0:Trustee42024-01-012024-12-3101676618ns0:Trustee52024-01-012024-12-3101676618ns0:Trustee22024-01-012024-12-3101676618ns0:Trustee62024-01-012024-12-3101676618ns0:Trustee72024-01-012024-12-3101676618ns0:Trustee82024-01-012024-12-3101676618ns0:Trustee92024-01-012024-12-3101676618ns0:Trustee102024-01-012024-12-3101676618ns0:Trustee112024-01-012024-12-3101676618ns0:Trustee12024-01-012024-12-3101676618ns0:Trustee122024-01-012024-12-3101676618ns0:Trustee132024-01-012024-12-3101676618ns0:Trustee142024-01-012024-12-3101676618ns0:Trustee152024-01-012024-12-3101676618ns11:CompanySecretary12024-01-012024-12-3101676618ns0:TotalUnrestrictedFunds2024-01-012024-12-3101676618ns0:TotalRestrictedIncomeFunds2024-01-012024-12-3101676618ns0:Activity82024-01-012024-12-3101676618ns0:TotalUnrestrictedFundsns0:Activity82024-01-012024-12-3101676618ns0:Activity8ns0:TotalRestrictedIncomeFunds2024-01-012024-12-3101676618ns0:Activity82023-01-012023-12-3101676618ns0:Activity92024-01-012024-12-3101676618ns0:TotalUnrestrictedFundsns0:Activity92024-01-012024-12-3101676618ns0:Activity9ns0:TotalRestrictedIncomeFunds2024-01-012024-12-3101676618ns0:Activity92023-01-012023-12-3101676618ns0:Activity102024-01-012024-12-3101676618ns0:TotalUnrestrictedFundsns0:Activity102024-01-012024-12-3101676618ns0:Activity10ns0:TotalRestrictedIncomeFunds2024-01-012024-12-3101676618ns0:Activity102023-01-012023-12-3101676618ns0:Activity112024-01-012024-12-3101676618ns0:Activity11ns0:TotalUnrestrictedFunds2024-01-012024-12-3101676618ns0:Activity11ns0:TotalRestrictedIncomeFunds2024-01-012024-12-3101676618ns0:Activity112023-01-012023-12-3101676618ns0:Activity122024-01-012024-12-3101676618ns0:Activity12ns0:TotalUnrestrictedFunds2024-01-012024-12-3101676618ns0:Activity12ns0:TotalRestrictedIncomeFunds2024-01-012024-12-3101676618ns0:Activity122023-01-012023-12-3101676618ns0:TotalUnrestrictedFunds2023-12-3101676618ns0:TotalRestrictedIncomeFunds2023-12-3101676618ns0:TotalUnrestrictedFunds2024-12-3101676618ns0:TotalRestrictedIncomeFunds2024-12-3101676618ns0:TotalUnrestrictedFundsns10:WithinOneYear2024-12-3101676618ns10:WithinOneYearns0:TotalRestrictedIncomeFunds2024-12-3101676618ns10:WithinOneYear2024-12-3101676618ns10:WithinOneYear2023-12-310167661822024-01-012024-12-3101676618ns0:TotalUnrestrictedFunds2023-01-012023-12-3101676618ns0:TotalRestrictedIncomeFunds2023-01-012023-12-3101676618ns0:TotalUnrestrictedFundsns0:Activity82023-01-012023-12-3101676618ns0:Activity8ns0:TotalRestrictedIncomeFunds2023-01-012023-12-3101676618ns0:TotalUnrestrictedFundsns0:Activity92023-01-012023-12-3101676618ns0:Activity9ns0:TotalRestrictedIncomeFunds2023-01-012023-12-3101676618ns0:TotalUnrestrictedFundsns0:Activity102023-01-012023-12-3101676618ns0:Activity10ns0:TotalRestrictedIncomeFunds2023-01-012023-12-3101676618ns0:Activity12ns0:TotalUnrestrictedFunds2023-01-012023-12-3101676618ns0:Activity12ns0:TotalRestrictedIncomeFunds2023-01-012023-12-31
REGISTERED COMPANY NUMBER: 01676618 (England and Wales)
REGISTERED CHARITY NUMBER: 286197

















REPORT OF THE TRUSTEES AND

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

BRITISH TOXICOLOGY SOCIETY(THE)

BRITISH TOXICOLOGY SOCIETY(THE)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024




Page

Report of the Trustees 1 to 2

Independent Examiner's Report 3

Statement of Financial Activities 4

Balance Sheet 5 to 6

Notes to the Financial Statements 7 to 13

BRITISH TOXICOLOGY SOCIETY(THE) (REGISTERED NUMBER: 01676618)

REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 31 DECEMBER 2024


The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 December 2024. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

OBJECTIVES AND ACTIVITIES
Objectives and significant activities
The Society is established for the promotion and advancement, for the public benefit, of education in the science of toxicology. In deciding the aims and activities of the society, the trustees have paid due regard to the guidance issued by the Charity Commission on public benefit. Toxicology is the science of disease induced by chemicals present in the diet, medicines, and in the environment. The British Toxicology Society (BTS) is a leading international toxicology society, based on the highest quality science, and promotes the advancement, communication and understanding of the scientific disciplines necessary to foster public health and environmental safety.

STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The Society is a company limited by guarantee and the liability of members is limited to an amount not exceeding £1. It is exempt under Section 60 of the Companies Act 2006 from the requirement to use the word 'Limited' in its title. The Society is governed by the Memorandum and Articles of Association. It is registered with the Charities Commission, number 286197, and no liability to taxation arises.
The Executive Committee are Directors for the purpose of company law and Trustees for the purpose of charity law. Directors/Trustees are appointed by the Society's members at the Annual General Meeting. When a Trustee retires, the Executive Committee nominates new Trustees. Additional nominations may be made by the membership, provided they are signed by six members of the Society.
Informal induction procedures are in place for new Trustees, conducted by an existing member of the Executive Committee and they are also provided with relevant documentation to formally advise and inform them of the Society's constitution and objectives and also their duties and responsibilities as a trustee.
One third of the Executive Committee ordinary members retire each year in rotation but are then eligible for re-election. The society is organised so that the Trustees, in the form of the Executive Committee, meet regularly, usually on a quarterly basis, to manage its affairs. There are also sub-committees which are responsible for advising and researching the various activities and development of the Society, who report to the Executive Committee.
Statutes for the workings of the various sub-committees are continually being revised and updated to ensure that the terms of reference are clearly defined and the ways of working are consistent. This also enables transparency of committee elections and duration of membership, while allowing the committees to work to agreed aims, backed up by comprehensive set of Standard Operating Procedures for the Society.
The trustees have assessed the major risks to which the Society is exposed, in particular those related to the operations and finances of the Society, and are satisfied that systems are in place to mitigate exposure to major risks.
All of the officers and members who serve on the Society's committees are unpaid. They are entitled to be reimbursed for any out of pocket expenses incurred in attending meetings.
No related parties, related party transactions, beneficial relationships or conflicts of interest requiring disclosure by the Charities' or Companies' Acts existed during the year.
Attendance by Executive Committee members has been reasonable throughout the year. The co-opted members continue to provide liaison with the relevant Sub-Committees and Speciality Sections.
The day to day administration of the Society is undertaken by an outside agency on a fee basis.

REFERENCE AND ADMINISTRATIVE DETAILS
Registered Company number
01676618 (England and Wales)

Registered Charity number
286197


BRITISH TOXICOLOGY SOCIETY(THE) (REGISTERED NUMBER: 01676618)

REPORT OF THE TRUSTEES
FOR THE YEAR ENDED 31 DECEMBER 2024

Registered office
Executive Business Support Limited
Stowe House
St Chad's Road
Lichfield
Staffordshire
WS13 6TJ

Trustees
Professor B G Lake Toxicologist (resigned 15/4/2024)
Dr E Marczylo Toxicologist (resigned 15/4/2024)
Dr D R Mason Toxicological Safety (resigned 15/4/2024)
Professor S C Price Professor Of Toxicology
Dr F Sewell Programme Manager
Dr P A Botham Toxicologist
Dr L M Reeve Toxicologist (resigned 15/4/2024)
Dr I Copple Senior Lecturer in Pharmacology
Dr B Ross Senior Consultant Toxicologist
Dr H Matar Associate Professor of Toxicology
Mrs F Hill Civil servant
Dr E Idahosa-Taylor Toxicologist
Prof V Stone Director (appointed 15/4/2024)
Prof T Gant Head of Toxicology (appointed 15/4/2024)
R Ghosh Principal Toxicologist (appointed 15/4/2024)

Company Secretary
Professor S C Price

Independent Examiner
Jonathon Dickens ACA
SMH BullockWoodburn
Norfolk House
Hardwick Square North
Buxton
SK17 6PU

Approved by order of the board of trustees on 19 June 2025 and signed on its behalf by:





Mrs F Hill - Trustee

INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF
BRITISH TOXICOLOGY SOCIETY(THE)

Independent examiner's report to the trustees of British Toxicology Society(The) ('the Company')
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 December 2024.

Responsibilities and basis of report
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.

Independent examiner's statement
Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a member of the Association of Chartered Certified Accountants, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.








Jonathon Dickens ACA

SMH BullockWoodburn
Norfolk House
Hardwick Square North
Buxton
SK17 6PU

7 May 2025

BRITISH TOXICOLOGY SOCIETY(THE)

STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 31 DECEMBER 2024

2024 2023
Unrestricted Restricted Total Total
fund funds funds funds
Notes £    £    £    £   
INCOME AND ENDOWMENTS FROM
Donations and legacies 84,966 5,000 89,966 73,364

Charitable activities
Annual Congress 147,675 - 147,675 122,191
Annual Congress trade exhibition 3,360 - 3,360 3,970
PATDD, ACT joint meetings, webinars and online events
10,622

-

10,622

10,790

Other trading activities 2 9,375 - 9,375 11,487
Investment income 3 12,549 285 12,834 7,468
Total 268,547 5,285 273,832 229,270

EXPENDITURE ON
Raising funds 4 25,430 - 25,430 22,404

Charitable activities 5
Annual Congress 156,817 - 156,817 137,856
Annual Congress trade exhibition - - - 107
PATDD, ACT joint meetings, webinars and online events
592

-

592

-
Donations and subscriptions to other societies 7,968 - 7,968 7,232
Travel bursaries and early career support 4,792 75 4,867 7,701

Other 62,867 - 62,867 43,669
Total 258,466 75 258,541 218,969

NET INCOME 10,081 5,210 15,291 10,301


RECONCILIATION OF FUNDS
Total funds brought forward 383,625 10,104 393,729 383,428

TOTAL FUNDS CARRIED FORWARD 393,706 15,314 409,020 393,729

BRITISH TOXICOLOGY SOCIETY(THE) (REGISTERED NUMBER: 01676618)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
Unrestricted Restricted Total Total
fund funds funds funds
Notes £    £    £    £   
CURRENT ASSETS
Debtors 9 74,282 - 74,282 65,125
Cash at bank 342,841 15,314 358,155 397,599
417,123 15,314 432,437 462,724

CREDITORS
Amounts falling due within one year 10 (23,417 ) - (23,417 ) (68,995 )

NET CURRENT ASSETS 393,706 15,314 409,020 393,729

TOTAL ASSETS LESS CURRENT LIABILITIES 393,706 15,314 409,020 393,729

NET ASSETS 393,706 15,314 409,020 393,729
FUNDS 11
Unrestricted funds 393,706 383,625
Restricted funds 15,314 10,104
TOTAL FUNDS 409,020 393,729

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.


The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.


The trustees acknowledge their responsibilities for
(a)ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.


BRITISH TOXICOLOGY SOCIETY(THE) (REGISTERED NUMBER: 01676618)

BALANCE SHEET - continued
31 DECEMBER 2024

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.


The financial statements were approved by the Board of Trustees and authorised for issue on 19 June 2025 and were signed on its behalf by:





F Hill - Trustee





S C Price - Trustee

BRITISH TOXICOLOGY SOCIETY(THE)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
There are no material uncertainties about the charity's ability to continue.
The trustees' assessment of the risks associated with Brexit and the pandemic are detailed in the President's report.

Financial reporting standard 102 - reduced disclosure exemptions
The charitable company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland':

the requirements of Section 7 Statement of Cash Flows;
the requirement of paragraph 3.17(d);
the requirements of paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and
11.48(c);
the requirements of paragraphs 12.26, 12.27, 12.29(a), 12.29(b) and 12.29A;
the requirement of paragraph 33.7.

Income
All incoming resources are included in the statement of financial activities when entitlement has passed to the charity; it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific policies are applied to particular categories of income:

- Income from donations or grants is recognised when there is evidence of entitlement to the gift, receipt is probable and its amount can be measured reliably.

- Legacy income is recognised when receipt is probable and entitlement is established.

- Income from donated goods is measured at the fair value of the goods unless this is impractical to measure reliably, in which case the value is derived from the cost to the donor or the estimated resale value. Donated facilities and services are recognised in the accounts when received if the value can be reliably measured. No amounts are included for the contribution of general volunteers.

- Income from contracts for the supply of services is recognised with the delivery of the contracted service. This is classified as unrestricted funds unless there is a contractual requirement for it to be spent on a particular purpose and returned if unspent, in which case it may be regarded as restricted.

Expenditure
Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, and is classified under headings of the statement of financial activities to which it relates:

- Expenditure on raising funds includes the costs of all fundraising activities, events, non-charitable trading activities, and the sale of donated goods.


BRITISH TOXICOLOGY SOCIETY(THE)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

1. ACCOUNTING POLICIES - continued

Expenditure
- Expenditure on charitable activities includes all costs incurred by a charity in undertaking activities that further its charitable aims for the benefit of its beneficiaries, including those support costs and costs relating to the governance of the charity apportioned to charitable activities.

- Other expenditure includes all expenditure that is neither related to raising funds for the charity nor part of its expenditure on charitable activities.

All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable, justifiable and consistent basis.

Taxation
The charity is exempt from corporation tax on its charitable activities.

Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

2. OTHER TRADING ACTIVITIES
2024 2023
Unrestricted Restricted Total Total
funds funds funds funds
£    £    £    £   
Website advertising 7,875 - 7,875 9,667
OUP / RSC Journal income 1,500 - 1,500 1,820
9,375 - 9,375 11,487

3. INVESTMENT INCOME
2024 2023
Unrestricted Restricted Total Total
funds funds funds funds
£    £    £    £   
Deposit account interest 12,549 285 12,834 7,468


BRITISH TOXICOLOGY SOCIETY(THE)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

4. RAISING FUNDS

Raising donations and legacies
2024 2023
Unrestricted Restricted Total Total
funds funds funds funds
£    £    £    £   
Bank charges 1,972 - 1,972 1,151
EBS - membership processing 12,226 - 12,226 11,677
Support costs 8,084 - 8,084 7,721
22,282 - 22,282 20,549


Other trading activities
2024 2023
Unrestricted Restricted Total Total
funds funds funds funds
£    £    £    £   
ACT webinars - - - 1,015
Bank charges 43 - 43 90
Speciality section meetings 1,100 - 1,100 -
Joint BPS-BTS meeting 2,005 - 2,005 -
Support costs - - - 750
3,148 - 3,148 1,855

Aggregate amounts 25,430 - 25,430 22,404

5. CHARITABLE ACTIVITIES COSTS
Support
Direct costs (see
Costs note 6) Totals
£    £    £   
Annual Congress 124,172 32,645 156,817
PATDD, ACT joint meetings, webinars
and online events

592

-

592
Donations and subscriptions to other
societies

6,121

1,847

7,968
Travel bursaries and early career
support

4,867

-

4,867
135,752 34,492 170,244


BRITISH TOXICOLOGY SOCIETY(THE)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

6. SUPPORT COSTS
Information Governance
Management Finance technology costs Totals
£    £    £    £    £   
Raising donations and
legacies

-

8,084

-

-

8,084

Other resources expended 9,046 6,739 39,417 7,665 62,867
Annual Congress 145 - - 32,500 32,645
Donations and
subscriptions to other
societies


-


1,347


500


-


1,847


9,191 16,170 39,917 40,165 105,443

7. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 December 2024 nor for the year ended 31 December 2023.


Trustees' expenses
2024 2023
£    £   
Trustees' expenses 1,068 187

8. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted Restricted Total
fund funds funds
£    £    £   
INCOME AND ENDOWMENTS FROM
Donations and legacies 73,364 - 73,364

Charitable activities
Annual Congress 122,191 - 122,191
Annual Congress trade exhibition 3,970 - 3,970
PATDD, ACT joint meetings, webinars and online events
10,790

-

10,790

Other trading activities 11,487 - 11,487
Investment income 7,378 90 7,468
Total 229,180 90 229,270

EXPENDITURE ON
Raising funds 22,404 - 22,404

Charitable activities
Annual Congress 137,856 - 137,856
Annual Congress trade exhibition 107 - 107
Donations and subscriptions to other societies
7,232

-

7,232
Travel bursaries and early career support 7,701 - 7,701


BRITISH TOXICOLOGY SOCIETY(THE)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

8. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted Restricted Total
fund funds funds
£    £    £   
Other 43,669 - 43,669
Total 218,969 - 218,969

NET INCOME 10,211 90 10,301


RECONCILIATION OF FUNDS
Total funds brought forward 373,414 10,014 383,428

TOTAL FUNDS CARRIED FORWARD 383,625 10,104 393,729

9. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Debtors 11,140 6,073
Prepayments & accrued income 63,142 59,052
74,282 65,125

10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 5,521 52,680
Accruals & prepaid income 17,896 16,315
23,417 68,995

11. MOVEMENT IN FUNDS
Net
movement At
At 1/1/24 in funds 31/12/24
£    £    £   
Unrestricted funds
General fund 383,625 10,081 393,706

Restricted funds
Barnes fund 814 22 836
Paton fund 3,812 107 3,919
Norman Aldridge fund 5,478 5,081 10,559
10,104 5,210 15,314
TOTAL FUNDS 393,729 15,291 409,020

BRITISH TOXICOLOGY SOCIETY(THE)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

11. MOVEMENT IN FUNDS - continued

Net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 268,547 (258,466 ) 10,081

Restricted funds
Barnes fund 22 - 22
Paton fund 107 - 107
Norman Aldridge fund 5,156 (75 ) 5,081
5,285 (75 ) 5,210
TOTAL FUNDS 273,832 (258,541 ) 15,291


Comparatives for movement in funds

Net
movement At
At 1/1/23 in funds 31/12/23
£    £    £   
Unrestricted funds
General fund 373,414 10,211 383,625

Restricted funds
Barnes fund 813 1 814
Paton fund 3,777 35 3,812
Norman Aldridge fund 5,424 54 5,478
10,014 90 10,104
TOTAL FUNDS 383,428 10,301 393,729

BRITISH TOXICOLOGY SOCIETY(THE)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

11. MOVEMENT IN FUNDS - continued

Comparative net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 229,180 (218,969 ) 10,211

Restricted funds
Barnes fund 1 - 1
Paton fund 35 - 35
Norman Aldridge fund 54 - 54
90 - 90
TOTAL FUNDS 229,270 (218,969 ) 10,301

Restricted funds comprise donations given to provide lecture awards, travel grants and support to early career toxicologists. Awards are made by the trustees on an alternate year basis.

12. RELATED PARTY DISCLOSURES

There were no related party transactions.